Aurinia Pharmaceuticals
AUPH
#4808
Rank
โ‚ฌ1.81 B
Marketcap
13,57ย โ‚ฌ
Share price
-1.59%
Change (1 day)
3.03%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2026 (TTM): โ‚ฌ0.14 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ0.32 Billion. In 2025 the company made an earning of โ‚ฌ0.10 Billion, an increase over its 2024 earnings that were of โ‚ฌ11.19 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ0.14 B37.64%
2025 โ‚ฌ0.10 B864.64%
2024 โ‚ฌ11.19 M-116.44%
2023 -โ‚ฌ68.07 Million-31.8%
2022 -โ‚ฌ99.81 Million-39.4%
2021 -โ‚ฌ0.17 Billion61.9%
2020 -โ‚ฌ0.11 Billion-9.73%
2019 -โ‚ฌ0.12 Billion92.65%
2018 -โ‚ฌ58.5 Million36.39%
2017 -โ‚ฌ42.89 Million106.29%
2016 -โ‚ฌ20.8 Million-15.4%
2015 -โ‚ฌ24.58 Million65.84%
2014 -โ‚ฌ14.82 Million129.82%
2013 -โ‚ฌ6.45 Million-26.6%
2012 -โ‚ฌ8.79 Million
2010 -โ‚ฌ4.98 Million-39.22%
2009 -โ‚ฌ8.19 Million-43.78%
2008 -โ‚ฌ14.56 Million-53.19%
2007 -โ‚ฌ31.1 Million42.97%
2006 -โ‚ฌ21.76 Million-23.03%
2005 -โ‚ฌ28.27 Million36.1%
2004 -โ‚ฌ20.77 Million172.57%
2003 -โ‚ฌ7.62 Million484.61%
2002 -โ‚ฌ1.31 Million
2000 -โ‚ฌ6.19 Million453.81%
1999 -โ‚ฌ1.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
โ‚ฌ5.18 B 3,225.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-โ‚ฌ20.16 Million-112.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-โ‚ฌ5 Million-103.21%๐Ÿ‡บ๐Ÿ‡ธ USA